Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Aestus Therapeutics Inc
Profile last edited on: 6/17/21      CAGE: 4FM90      UEI:

Business Identifier: Treatment of neuropathic pain
Year Founded
2006
First Award
2007
Latest Award
2011
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

104 Windsor Center Drive
East Windsor, NJ 08520
   (732) 249-0690
   thonore@aestustherapeutics.com
   www.aestustx.com
Location: Single
Congr. District: 12
County: Mercer

Public Profile

Aestus Therapeutics Inc iws establsihed as a private translational medicine company originally organized around treatment of disorders of the nervous system: neuropathic pain. Aestus’ core technology utilized a unique and proprietary set of processes for mining the vast amount of public genomic and pharmaceutical data to generate novel associations between biological targets and diseases to form the basis for new therapeutic approaches. The firmappers to have discontinued operations some time during 2014

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$198,960
Phase II Dollars
$2,289,965
Total Awarded
$2,488,925

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2011 2 NIH $2,488,925
Project Title: Accelerated Discovery and Development of New Pain Therapeutics

Key People / Management

  Tage Honore -- President

  Lillian W Chiang -- co-founder

  F Aaron Dubberley -- Director of Intellectual Properties

  Daniel J Lavery -- Director of Research and Genomics

  Lisa McCormick -- Media Contact

Company News

Dec 13 2011
Aestus Therapeutics reports positive results in Phase II neuropathic pain trial for treatment of post herpetic neuralg
Sep 19 2011
Aestus Therapeutics and Prosidion Ltd Sign License Agreement for Novel Chronic Pain Therapeutic